QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]
Sponsors
Quantum Genomics SA
Conditions
Essential Hypertension
Phase 1
Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo
CompletedNCT01900171
Start: 2012-02-29End: 2012-05-31Updated: 2013-07-16
Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects
CompletedNCT01900184
Start: 2012-12-31End: 2013-03-31Updated: 2013-07-16